2023-01-062023-01-062022-07-26Xu K, Khan M, Yu J, Snyder NW, Wu S, Vazquez-Padron RI, Wang H and Yang X (2022) Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics. Front. Cardiovasc. Med. 9:981544. doi: 10.3389/fcvm.2022.9815442297-055Xhttp://dx.doi.org/10.34944/dspace/8239http://hdl.handle.net/20.500.12613/8268With the effort and support of the authors, editorial office, and editorial team, the Frontiers in Cardiovascular Medicine, Cardiovascular Therapeutics Section-Research Topic “Insights in Cardiovascular Therapeutics: 2021” has achieved great success and is attracting interest from the cardiovascular community. Here, we spotlight 12 studies published in our section that related to cell death and cardiovascular injuries, as well as some recent advances in the field that have tremendous potential in cardiovascular therapy. In addition, these highlights may serve as the foundation for some new developments in our Cardiovascular Therapeutics areas. In 2022, we will keep working to create a fantastic platform for cardiologists, translational cardiovascular scientists, and cardiovascular pharmacological scientists to share new results and data in clinical cardiology and translational cardiovascular therapeutics.5 pagesengAttribution CC BYhttps://creativecommons.org/licenses/by/4.0/Cell deathCardiovascular injuriesNovel targetsCardiovascular therapeuticsInflammationText